CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Oct. 31, 2017	Oct. 31, 2016
Revenue	$ 362,500	$ 300,000
Operating costs and expenses:
Inventor royalties and contingent legal fees	91,451	111,192
Litigation and licensing expenses	13,105	106,224
Amortization of patents	325,296	325,296
Research and development expenses (including non-cash stock option compensation expenses of $288,187 and $259,930, respectively)	1,597,550	1,556,459
Marketing, general and administrative expenses (including non-cash stock option compensation expense of $934,585 and $613,631, respectively)	4,410,682	2,709,841
Total operating costs and expenses	6,438,084	4,809,012
Loss from operations	(6,075,584)	(4,509,012)
Gain on extinguishment of patent acquisition obligation (Note 4)	1,547,608
Interest expense (Notes 4 and 5)	(500,455)	(519,946)
Interest income	19,440	12,530
Loss before income taxes	(5,008,991)	(5,016,428)
Provision for income taxes (Note 7)
Net loss	(5,008,991)	(5,016,428)
Deemed dividend to preferred stockholder (Note 5)	(2,008,775)
Net loss attributable to common stockholders	$ (7,017,766)	$ (5,016,428)
Net loss per share:
Basic and diluted (in Dollars per share)	$ (0.58)	$ (0.57)
Weighted average common shares outstanding:
Basic and diluted (in Shares)	12,197,340	8,739,453